+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030- Product Image
New

Immunoassay Market Size, Share & Trends Analysis Report By Product, By Technology (Radioimmunoassay, Enzyme Immunoassays), By Application (Therapeutic Drug Monitoring, Oncology), By Specimen (Blood), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2025
  • Region: Global
  • Grand View Research
  • ID: 5415506
Description Jump to:
The global immunoassay market size is expected to reach USD 35.10 billion by 2030, registering a CAGR of 4.59% from 2025 to 2030. The introduction of PoC rapid tests and automated immunoassay analyzers is boosting market growth. In addition, the rising number of chronic and infectious diseases is leading to high market growth.

According to the American Cancer Society, there were an estimated 16.9 million cancer patients/survivors in 2020. Around 1.8 million cancer cases were diagnosed in the U.S., according to the National Cancer Institute 2019 data. According to the American Cancer Society, nearly 606,880 deaths occurred due to cancer in the U.S. in 2019. Thus, the rise in the number of cancer cases being diagnosed is driving the demand for immunoassays. This is expected to boost the market growth in the coming years.

Furthermore, growing awareness regarding infectious diseases and preventive measures has led to a high demand for rapid diagnostic test products, thereby increasing sales. Based on a survey by the WHO on the World malaria report 2018, manufacturers reported sales of 276 million for lateral flow assays in 2017. It also reported that around 75.0% of malaria cases were diagnosed using lateral flow assays in sub-Saharan Africa in 2017.

Several smartphone-based devices and associated tools have emerged as next-generation point-of-care diagnostics or testing devices, thereby boosting the market growth. For instance, a smartphone application combined with the autonomous capillary microfluidic chip is used for the rapid testing of cardiac troponin I in myocardial infarction. This platform can be easily used in resource-limited settings, providing test results within 12 minutes. Thus, novel technological advancements are anticipated to further drive the market over the forecast period.

The first implementation of the Atellica immunoassay solutions with Aptio automation in the United States was announced by Siemens Healthcare GmbH in April 2018. The objective of this product was designed to promote advanced technological products in the U.S. In December 2020, Beckman Coulter, a Danaher business, introduced its first high-quality as well as throughput assay for the COVID-19 antigen detection, officially named Access SARS-CoV-2 Antigen assay. In July 2018, Cygnus Technologies and Gyros Protein Technologies collaborated to produce immunoassay to identify biotherapeutic toxins. The two companies' strategic alliance will primarily focus on offering bioanalytical solutions and increasing biotherapeutics manufacturing efficiencies.

Immunoassay Market Report Highlights

  • In 2024, kits and reagents led the market with a 66.10% share, driven by increasing demand for personalized medicine and targeted therapies for diseases. However, the software and services of the immunoassays segment is projected to grow at the fastest CAGR during the forecast period and are delivering testing services for clinical and research uses.
  • The infectious disease application in the immunoassay industry led the market with a 66.10% share and is expected to grow at a CAGR of 5.43% over the forecast period. Oncology and autoimmune diseases are projected to grow at a significant growth during the forecast period.
  • Enzyme immunoassays secured the dominant market share in 2024 of 63.90% focusing on personalized medicine, cancer diagnostics, cardiovascular disease testing, and infectious disease detection. However, the others segment is projected to grow at the fastest CAGR during the forecast period.
  • Blood held the largest market share of 41.54% in 2024, being the largest specimen used for performing immunoassays. Urine is expected to be the fastest-growing segment over the forecast period, driven by its non-invasive nature, ease of collection, and widespread application in disease diagnostics.
  • In 2024, the hospitals in the immunoassay industry held a 32.54% share. Others are projected to grow at a CAGR of 5.45% during the forecast period.
  • North America immunoassay market held the largest revenue share at 47.43% in 2024, primarily supported by robust healthcare systems, a high incidence of chronic illnesses, and a growing awareness of new diagnostic technologies. Asia Pacific is set to record the fastest CAGR, propelled by healthcare reforms, infrastructure enhancements, and a large patient pool.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This Report Addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Immunoassay Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.1.1. Rising incidence of chronic and infectious diseases
3.3.1.2. Increasing demand for point-of-care diagnostics
3.3.1.3. Growing demand for portable and automated immunoassays
3.3.2. Market Restraints Analysis
3.3.2.1. Lower detection limit
3.3.2.2. Limitations associated with immunoassay techniques
3.4. Immunoassay Market Analysis Tools
3.4.1. Porter’s Five Forces Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Immunoassay Market: Product Estimates & Trend Analysis
4.1. Immunoassay Market: Product Movement Analysis
4.2. Immunoassay Market Estimates and Forecasts, by Product 2024 & 2030 (USD Million)
4.3. Assays, Kits, and Reagents
4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. ELISA Reagents & Kits
4.3.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Rapid Tests Reagents & Kits
4.3.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. ELISPOT Reagents & Kits
4.3.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Western Blot Reagents & Kits
4.3.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.6. Other Reagents & Kits
4.3.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Analyzers/Instruments
4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Open Ended Systems
4.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Closed Ended Systems
4.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Software and Services
4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Immunoassay Market: Application Estimates & Trend Analysis
5.1. Immunoassay Market: Application Movement Analysis
5.2. Immunoassay Market Estimates and Forecasts, by Application 2024 & 2030 (USD Million)
5.3. Therapeutic Drug Monitoring
5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oncology
5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiology
5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Endocrinology
5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Infectious Disease Testing
5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autoimmune Diseases
5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Others
5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Immunoassay Market: Technology Estimates & Trend Analysis
6.1. Immunoassay Market: Technology Movement Analysis
6.2. Immunoassay Market Estimates and Forecasts, by Technology 2024 & 2030 (USD Million)
6.3. Radioimmunoassay (RIA)
6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Enzyme Immunoassays (EIA)
6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.2. Chemiluminescence Immunoassays (CLIA)
6.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4.3. Fluorescence Immunoassays (FIA)
6.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Rapid Test
6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Others
6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Immunoassay Market: Specimen Estimates & Trend Analysis
7.1. Immunoassay Market: Specimen Movement Analysis
7.2. Immunoassay Market Estimates and Forecasts, by Specimen 2024 & 2030 (USD Million)
7.3. Blood
7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Saliva
7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Urine
7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Others
7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Immunoassay Market: End Use Estimates & Trend Analysis
8.1. Immunoassay Market: End--use Movement Analysis
8.2. Immunoassay Market Estimates and Forecasts, by End-use 2024 & 2030 (USD Million)
8.3. Hospitals
8.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Blood Banks
8.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Clinical Laboratories
8.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Pharmaceutical and Biotech Companies
8.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.7. Academic Research Centers
8.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.8. Others
8.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Immunoassay Market: Regional Estimates & Trend Analysis
9.1. Immunoassay Market Share, By Region, 2024 & 2030 (USD Million)
9.2. North America
9.2.1. North America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Target Disease Prevalence
9.2.2.3. Competitive Scenario
9.2.2.4. Regulatory Framework
9.2.2.5. Reimbursement Scenario
9.2.2.6. U.S. Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Target Disease Prevalence
9.2.3.3. Competitive Scenario
9.2.3.4. Regulatory Framework
9.2.3.5. Reimbursement Scenario
9.2.3.6. Canada Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Key Country Dynamics
9.2.4.2. Target Disease Prevalence
9.2.4.3. Competitive Scenario
9.2.4.4. Regulatory Framework
9.2.4.5. Reimbursement Scenario
9.2.4.6. Mexico Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Target Disease Prevalence
9.3.2.3. Competitive Scenario
9.3.2.4. Regulatory Framework
9.3.2.5. Reimbursement Scenario
9.3.2.6. UK Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Target Disease Prevalence
9.3.3.3. Competitive Scenario
9.3.3.4. Regulatory Framework
9.3.3.5. Reimbursement Scenario
9.3.3.6. Germany Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Target Disease Prevalence
9.3.4.3. Competitive Scenario
9.3.4.4. Regulatory Framework
9.3.4.5. Reimbursement Scenario
9.3.4.6. France Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Target Disease Prevalence
9.3.5.3. Competitive Scenario
9.3.5.4. Regulatory Framework
9.3.5.5. Reimbursement Scenario
9.3.5.6. Italy Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Target Disease Prevalence
9.3.6.3. Competitive Scenario
9.3.6.4. Regulatory Framework
9.3.6.5. Reimbursement Scenario
9.3.6.6. Spain Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Target Disease Prevalence
9.3.7.3. Competitive Scenario
9.3.7.4. Regulatory Framework
9.3.7.5. Reimbursement Scenario
9.3.7.6. Denmark Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Target Disease Prevalence
9.3.8.3. Competitive Scenario
9.3.8.4. Regulatory Framework
9.3.8.5. Reimbursement Scenario
9.3.8.6. Sweden Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Target Disease Prevalence
9.3.9.3. Competitive Scenario
9.3.9.4. Regulatory Framework
9.3.9.5. Reimbursement Scenario
9.3.9.6. Norway Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Target Disease Prevalence
9.4.2.3. Competitive Scenario
9.4.2.4. Regulatory Framework
9.4.2.5. Reimbursement Scenario
9.4.2.6. Japan Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Target Disease Prevalence
9.4.3.3. Competitive Scenario
9.4.3.4. Regulatory Framework
9.4.3.5. Reimbursement Scenario
9.4.3.6. China Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Target Disease Prevalence
9.4.4.3. Competitive Scenario
9.4.4.4. Regulatory Framework
9.4.4.5. Reimbursement Scenario
9.4.4.6. India Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Target Disease Prevalence
9.4.5.3. Competitive Scenario
9.4.5.4. Regulatory Framework
9.4.5.5. Reimbursement Scenario
9.4.5.6. Australia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. Key Country Dynamics
9.4.6.2. Target Disease Prevalence
9.4.6.3. Competitive Scenario
9.4.6.4. Regulatory Framework
9.4.6.5. Reimbursement Scenario
9.4.6.6. South Korea Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Key Country Dynamics
9.4.7.2. Target Disease Prevalence
9.4.7.3. Competitive Scenario
9.4.7.4. Regulatory Framework
9.4.7.5. Reimbursement Scenario
9.4.7.6. Thailand Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Target Disease Prevalence
9.5.2.3. Competitive Scenario
9.5.2.4. Regulatory Framework
9.5.2.5. Reimbursement Scenario
9.5.2.6. Brazil Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Key Country Dynamics
9.5.3.2. Target Disease Prevalence
9.5.3.3. Competitive Scenario
9.5.3.4. Regulatory Framework
9.5.3.5. Reimbursement Scenario
9.5.3.6. Argentina Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Target Disease Prevalence
9.6.2.3. Competitive Scenario
9.6.2.4. Regulatory Framework
9.6.2.5. Reimbursement Scenario
9.6.2.6. South Africa Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Target Disease Prevalence
9.6.3.3. Competitive Scenario
9.6.3.4. Regulatory Framework
9.6.3.5. Reimbursement Scenario
9.6.3.6. Saudi Arabia Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Target Disease Prevalence
9.6.4.3. Competitive Scenario
9.6.4.4. Regulatory Framework
9.6.4.5. Reimbursement Scenario
9.6.4.6. UAE Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Target Disease Prevalence
9.6.5.3. Competitive Scenario
9.6.5.4. Regulatory Framework
9.6.5.5. Reimbursement Scenario
9.6.5.6. Kuwait Immunoassay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.5. Abbott
10.5.1. Participant’s Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Recent Developments/ Strategic Initiatives
10.6. Siemens Healthineers AG
10.6.1. Participant’s Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Recent Developments/ Strategic Initiatives
10.7. Danaher Corporation (Beckman Coulter)
10.7.1. Participant’s Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Recent Developments/ Strategic Initiatives
10.8. bioMérieux SA
10.8.1. Participant’s Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Recent Developments/ Strategic Initiatives
10.9. Quidel Corporation
10.9.1. Participant’s Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Recent Developments/ Strategic Initiatives
10.10. Sysmex Corporation
10.10.1. Participant’s Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Recent Developments/ Strategic Initiatives
10.11. Ortho Clinical Diagnostics
10.11.1. Participant’s Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Recent Developments/ Strategic Initiatives
10.12. Bio-Rad Laboratories, Inc.
10.12.1. Participant’s Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Recent Developments/ Strategic Initiatives
10.13. F. Hoffmann-La Roche AG
10.13.1. Participant’s Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Recent Developments/ Strategic Initiatives
10.14. Becton, Dickinson, and Company
10.14.1. Participant’s Overview
10.14.2. Financial Performance
10.14.3. Product Benchmarking
10.14.4. Recent Developments/ Strategic Initiatives
10.15. Thermo Fisher Scientific, Inc.
10.15.1. Participant’s Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global immunoassay market, by region, 2018 - 2030 (USD Million)
Table 3 Global immunoassay market, by product, 2018 - 2030 (USD Million)
Table 4 Global immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 5 Global immunoassay market, by application, 2018 - 2030 (USD Million)
Table 6 Global immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 7 Global immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 8 North America immunoassay market, by country, 2018 - 2030 (USD Million)
Table 9 North America immunoassay market, by product, 2018 - 2030 (USD Million)
Table 10 North America immunoassay market, by application, 2018 - 2030 (USD Million)
Table 11 North America immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 12 North America immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 13 North America immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 14 U.S. immunoassay market, by product, 2018 - 2030 (USD Million)
Table 15 U.S. immunoassay market, by application, 2018 - 2030 (USD Million)
Table 16 U.S. immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 17 U.S. immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 18 U.S. immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 19 Canada immunoassay market, by product, 2018 - 2030 (USD Million)
Table 20 Canada immunoassay market, by application, 2018 - 2030 (USD Million)
Table 21 Canada immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 22 Canada immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 23 Canada immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 24 Mexico immunoassay market, by product, 2018 - 2030 (USD Million)
Table 25 Mexico immunoassay market, by application, 2018 - 2030 (USD Million)
Table 26 Mexico immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 27 Mexico immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 28 Mexico immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 29 Europe immunoassay market, by country, 2018 - 2030 (USD Million)
Table 30 Europe immunoassay market, by product, 2018 - 2030 (USD Million)
Table 31 Europe immunoassay market, by application, 2018 - 2030 (USD Million)
Table 32 Europe immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 33 Europe immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 34 Europe immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 35 UK immunoassay market, by product, 2018 - 2030 (USD Million)
Table 36 UK immunoassay market, by application, 2018 - 2030 (USD Million)
Table 37 UK immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 38 UK immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 39 UK immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 40 Germany immunoassay market, by product, 2018 - 2030 (USD Million)
Table 41 Germany immunoassay market, by application, 2018 - 2030 (USD Million)
Table 42 Germany immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 43 Germany immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 44 Germany immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 45 France immunoassay market, by product, 2018 - 2030 (USD Million)
Table 46 France immunoassay market, by application, 2018 - 2030 (USD Million)
Table 47 France immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 48 France immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 49 France immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 50 Italy immunoassay market, by product, 2018 - 2030 (USD Million)
Table 51 Italy immunoassay market, by application, 2018 - 2030 (USD Million)
Table 52 Italy immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 53 Italy immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 54 Italy immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 55 Spain immunoassay market, by product, 2018 - 2030 (USD Million)
Table 56 Spain immunoassay market, by application, 2018 - 2030 (USD Million)
Table 57 Spain immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 58 Spain immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 59 Spain immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 60 Denmark immunoassay market, by product, 2018 - 2030 (USD Million)
Table 61 Denmark immunoassay market, by application, 2018 - 2030 (USD Million)
Table 62 Denmark immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 63 Denmark immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 64 Denmark immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 65 Sweden immunoassay market, by product, 2018 - 2030 (USD Million)
Table 66 Sweden immunoassay market, by application, 2018 - 2030 (USD Million)
Table 67 Sweden immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 68 Sweden immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 69 Sweden immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 70 Norway immunoassay market, by product, 2018 - 2030 (USD Million)
Table 71 Norway immunoassay market, by application, 2018 - 2030 (USD Million)
Table 72 Norway immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 73 Norway immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 74 Norway immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 75 Asia Pacific immunoassay market, by country, 2018 - 2030 (USD Million)
Table 76 Asia Pacific immunoassay market, by product, 2018 - 2030 (USD Million)
Table 77 Asia Pacific immunoassay market, by application, 2018 - 2030 (USD Million)
Table 78 Asia Pacific immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 79 Asia Pacific immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 80 Asia Pacific immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 81 Japan immunoassay market, by product, 2018 - 2030 (USD Million)
Table 82 Japan immunoassay market, by application, 2018 - 2030 (USD Million)
Table 83 Japan immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 84 Japan immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 85 Japan immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 86 China immunoassay market, by product, 2018 - 2030 (USD Million)
Table 87 China immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 88 China immunoassay market, by application, 2018 - 2030 (USD Million)
Table 89 China immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 90 China immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 91 India immunoassay market, by product, 2018 - 2030 (USD Million)
Table 92 India immunoassay market, by application, 2018 - 2030 (USD Million)
Table 93 India immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 94 India immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 95 India immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 96 Australia immunoassay market, by product, 2018 - 2030 (USD Million)
Table 97 Australia immunoassay market, by application, 2018 - 2030 (USD Million)
Table 98 Australia immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 99 Australia immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 100 Australia immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 101 South Korea immunoassay market, by product, 2018 - 2030 (USD Million)
Table 102 South Korea immunoassay market, by application, 2018 - 2030 (USD Million)
Table 103 South Korea immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 104 South Korea immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 105 South Korea immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 106 Thailand immunoassay market, by product, 2018 - 2030 (USD Million)
Table 107 Thailand immunoassay market, by application, 2018 - 2030 (USD Million)
Table 108 Thailand immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 109 Thailand immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 110 Thailand immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 111 Latin America immunoassay market, by country, 2018 - 2030 (USD Million)
Table 112 Latin America immunoassay market, by product, 2018 - 2030 (USD Million)
Table 113 Latin America immunoassay market, by application, 2018 - 2030 (USD Million)
Table 114 Latin America immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 115 Latin America immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 116 Latin America immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 117 Brazil immunoassay market, by product, 2018 - 2030 (USD Million)
Table 118 Brazil immunoassay market, by application, 2018 - 2030 (USD Million)
Table 119 Brazil immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 120 Brazil immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 121 Brazil immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 122 Argentina immunoassay market, by product, 2018 - 2030 (USD Million)
Table 123 Argentina immunoassay market, by application, 2018 - 2030 (USD Million)
Table 124 Argentina immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 125 Argentina immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 126 Argentina immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 127 MEA immunoassay market, by country, 2018 - 2030 (USD Million)
Table 128 MEA immunoassay market, by product, 2018 - 2030 (USD Million)
Table 129 MEA immunoassay market, by application, 2018 - 2030 (USD Million)
Table 130 MEA immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 131 MEA immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 132 MEA immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 133 South Africa immunoassay market, by product, 2018 - 2030 (USD Million)
Table 134 South Africa immunoassay market, by application, 2018 - 2030 (USD Million)
Table 135 South Africa immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 136 South Africa immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 137 South Africa immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 138 Saudi Arabia immunoassay market, by product, 2018 - 2030 (USD Million)
Table 139 Saudi Arabia immunoassay market, by application, 2018 - 2030 (USD Million)
Table 140 Saudi Arabia immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 141 Saudi Arabia immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 142 Saudi Arabia immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 143 UAE immunoassay market, by product, 2018 - 2030 (USD Million)
Table 144 UAE immunoassay market, by application, 2018 - 2030 (USD Million)
Table 145 UAE immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 146 UAE immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 147 UAE immunoassay market, by end-use, 2018 - 2030 (USD Million)
Table 148 Kuwait immunoassay market, by product, 2018 - 2030 (USD Million)
Table 149 Kuwait immunoassay market, by application, 2018 - 2030 (USD Million)
Table 150 Kuwait immunoassay market, by technology, 2018 - 2030 (USD Million)
Table 151 Kuwait immunoassay market, by specimen, 2018 - 2030 (USD Million)
Table 152 Kuwait immunoassay market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Immunoassay market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot-1
Fig. 14 Segment snapshot-2
Fig. 15 Competitive landscape snapshot
Fig. 16 Market trends & outlook
Fig. 17 Porter’s five force analysis
Fig. 18 PESTEL analysis
Fig. 19 Immunoassay market: Product outlook key takeaways
Fig. 20 Immunoassay market: Product movement analysis
Fig. 21 Assays, kits, and reagents market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 ELISA Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Rapid Tests Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 ELISPOT Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Western Blot Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Analyzers/Instruments and systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Software and services market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Open Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Closed Ended Systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Immunoassay market: Application outlook key takeaways
Fig. 32 Immunoassay market: Application movement analysis
Fig. 33 Therapeutic Drug Monitoring
Fig. 34 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Cardiology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Endocrinology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Infectious Disease Testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Autoimmune Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Immunoassay market: Technology outlook key takeaways
Fig. 41 Immunoassay market: Technology movement analysis
Fig. 42 Radioimmunoassay (RIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Enzyme Immunoassays (EIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Rapid Test market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Chemiluminescence Immunoassays (CLIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Fluorescence Immunoassays (FIA) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Immunoassay market: Specimen outlook key takeaways
Fig. 49 Immunoassay market: Specimen movement analysis
Fig. 50 Blood market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Saliva market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Immunoassay market: End-use outlook key takeaways
Fig. 55 Immunoassay market: End-use movement analysis
Fig. 56 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Blood Banks market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Clinical Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Pharmaceutical and Biotech Companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Academic Research Centers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 Regional marketplace outlook, 2024 & 2030 (USD Million)
Fig. 63 Regional marketplace: Key takeaways
Fig. 64 North America immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 U.S. immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Canada immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Mexico immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Europe immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 UK immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 Germany immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 France immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Spain immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 Italy immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Denmark immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Key country dynamics
Fig. 85 Sweden immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 Key country dynamics
Fig. 87 Norway immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 88 Asia Pacific immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Key country dynamics
Fig. 90 Japan immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 91 Key country dynamics
Fig. 92 China immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 93 Key country dynamics
Fig. 94 India immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Key country dynamics
Fig. 96 Australia immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 97 Key country dynamics
Fig. 98 South Korea immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 99 Key country dynamics
Fig. 100 Thailand immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Key country dynamics
Fig. 102 Market participant categorization
Fig. 103 Immunoassay market position analysis, 2023
Fig. 104 Strategic framework

Companies Mentioned

  • Abbott
  • Siemens Healthineers
  • Danaher Corporation (Beckman Coulter)
  • bioMérieux SA
  • Quidel Corporation
  • Sysmex Corporation
  • Ortho Clinical Diagnostics
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Becton, Dickinson, and Company
  • Thermo Fisher Scientific, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMarch 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 26.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 35.1 Billion
Compound Annual Growth Rate4.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Enzyme Immunoassay Market Size, Share & Trends Analysis Report by Product (Reagents & Kits, Software & Services), Application (Oncology, Cardiology), Specimen, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 120 Pages
  • Global
From
In-Vitro Diagnostics Market by Product Type (Instruments, Reagents & Kits, Services), Test Type (Clinical Chemistry, Hematology, Immunoassays), Specimen, Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Market by Product Type (Instruments, Reagents & Kits, Services), Test Type (Clinical Chemistry, Hematology, Immunoassays), Specimen, Application, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2025-2030 - Product Image

Immunoassay Market by Type, Technology, Instruments, Sample Types, Detection Modes, Application Areas, End Users, Deployment Types - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Immunoassay - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030 - Product Image

Immunoassay Analyzers Market Size, Share & Trends Analysis Report By Product (Chemiluminescence Immunoassays, Fluorescence Immunoassay, Radioimmunoassay), By Application (Oncology, Cardiology), By End-use, By Region And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.